Research Article | Volume: 2 Issue: 8, August 2012

In-vitro bioequivalence study of 8 brands of metformin tablets in Iran market

Parvin Zakeri-Milani Peyman Nayyeri-Maleki Saeed Ghanbarzadeh Mahboob Nemati Hadi Valizadeh   

Open Access    DOI: 10.7324/JAPS.2012.2834

Abstract

Bioequivalence studies are the commonly accepted methods displaying therapeutic equivalence between two products .This study was conducted to evaluate the bioequivalence between different formulations of metformin 500 mg and 1000 mg tablets which were marketed in Iran, and innovator brand. Considering that only in vitro bioequivalence studies can predict the in vivo bioequivalence, and to save time and cost, three essential in vitro tests including assay, weight variation and a comparative in vitro dissolution study were performed. In order to compare formulations, dissolution profiles were taken and compared through two model independent methods, difference factor (f1) and similarity factor (f2). All the tested brands released more than 80% drug in 30 minutes and contained 95-96.3% of labeled amount except b and C. The acceptance value in all cases were below 15. Therefore it is evident that test products except brand C were bioequivalent to the reference product, and could be used as a generic substitute for the innovator product. Results emphasize to need for post marketing investigation for new formulations.


Keyword:     Metformin tabletsBioequivalenceIn vitroDissolution profile.


Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Article Metrics
391 Views 83 Downloads 474 Total

Year

Month

Related Search

By author names